GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Other Current Liabilities

TheraCryf (FRA:8EV) Other Current Liabilities : €0.00 Mil (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Other Current Liabilities?

TheraCryf's other current liabilities for the quarter that ended in Sep. 2023 was €0.00 Mil.

TheraCryf's quarterly other current liabilities increased from Sep. 2022 (€0.00 Mil) to Mar. 2023 (€0.44 Mil) but then declined from Mar. 2023 (€0.44 Mil) to Sep. 2023 (€0.00 Mil).

TheraCryf's annual other current liabilities increased from Mar. 2021 (€0.20 Mil) to Mar. 2022 (€0.38 Mil) and increased from Mar. 2022 (€0.38 Mil) to Mar. 2023 (€0.44 Mil).


TheraCryf Other Current Liabilities Historical Data

The historical data trend for TheraCryf's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Other Current Liabilities Chart

TheraCryf Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TheraCryf Semi-Annual Data
Mar13 Mar14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TheraCryf Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


TheraCryf Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of TheraCryf's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


TheraCryf (FRA:8EV) Business Description

Industry
Traded in Other Exchanges
Address
Congleton Road, Suite 24G13- Block 24, Alderley Park, Nether Alderley, GBR, SK10 4TG
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.

TheraCryf (FRA:8EV) Headlines

No Headlines